Author:
Habu Takumi,Kumanishi Ryosuke,Ogata Takatsugu,Fujisawa Takeshi,Mishima Saori,Kotani Daisuke,Kadowaki Shigenori,Nakamura Masaki,Hojo Hidehiro,Fujiwara Hisashi,Kumagai Shogo,Koyama Shohei,Fujita Takeo,Kinoshita Takahiro,Nishikawa Hiroyoshi,Yano Tomonori,Tajika Masahiro,Muro Kei,Mitsunaga Shuichi,Kojima Takashi,Bando Hideaki
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Cancer mortality from Vital Statistics in Japan (1958-2020). Cancer Statistics. Cancer Information Service, National Cancer Center, Japan (Vital Statistics of Japan, Ministry of Health, Labour and Welfare). 2023. https://ganjoho.jp/reg_stat/statistics/data/dl/en.html.
2. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th edition: part II and III. Esophagus. 2017;14(1):37–65.
3. Watanabe M, Toh Y, Ishihara R, et al. Comprehensive registry of esophageal cancer in Japan, 2014. Esophagus. 2022;19(1):1–26.
4. Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/ Japan Clinical Oncology Group Trial (JCOG9516). Jpn J Clin Oncol. 2004;34(10):615–9.
5. Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17(9):2915–21.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献